5-FU wekelijks

Middelen Fluorouracil (5-FU) Folinezuur

5-FU/Bevacizumab 2 wekelijks

Middelen Bevacizumab Fluorouracil (5-FU) Folinezuur

Abiraterone

Middelen Abirateron

ABVD

Middelen Bleomycine Dacarbazine Doxorubicine Vinblastine

AC

Middelen Cyclofosfamide Doxorubicine

AC Pembrolizumab

Middelen Cyclofosfamide Doxorubicine Pembrolizumab

AC/Docetaxel

Middelen Cyclofosfamide Docetaxel Doxorubicine

AC/DT

Middelen Cyclofosfamide Docetaxel Doxorubicine Trastuzumab

AC/Paclitaxel

Middelen Cyclofosfamide Doxorubicine Paclitaxel

AC/PT deel A

Middelen Cyclofosfamide Doxorubicine

AC/PT deelB (neo)adjuvant)

Middelen Paclitaxel Trastuzumab

Alemtuzumab

Middelen Alemtuzumab

ANCA vasculitis: Cyclofosfamide

Middelen Cyclofosfamide

Atezolizumab/Bevacizumab

Middelen Atezolizumab Bevacizumab

Avelumab

Middelen Avelumab

Azacitidine

Middelen Azacitidine - oraal

Azacitidine - Venetoclax

Middelen Azacitidine - oraal Venetoclax

BEACOPP escalated

Middelen Bleomycine Cyclofosfamide Doxorubicine Etoposide Procarbazine Vincristine

Bendamustine

Middelen Bendamustine

Bevacizumab (Avastin)

Middelen Bevacizumab

Bortezomib dag 1, 4, 8 en 11 /dexamethason

Middelen Bortezomib Dexamethason

Bortezomib dag 1, 8, 15 en 22 (wekelijks)/dexamethason

Middelen Bortezomib Dexamethason

Bortezomib/dexamethason + rituximab

Middelen Bortezomib Dexamethason Rituximab

Bosutinib

Middelen Bosutinib

Brentuximab

Middelen Brentuximab vedotin

Cabazitaxel

Middelen Cabazitaxel

CAIRO 5 studie: Folfirinox + bevacizumab

Middelen Bevacizumab Fluorouracil (5-FU) Irinotecan Oxaliplatine

CAIRO 5: FOLFOX6 + bevacizumab

CAIRO 5: FOLFOX6 + panitumumab

CAP

Middelen Cisplatine Cyclofosfamide Doxorubicine

Capecitabine

Middelen Capecitabine

Capecitabine + radiotherapie (rectumcarcinoom)

Middelen Capecitabine

Capecitabine + radiotherapie (vulvacarcinoom)

Middelen Capecitabine

Capecitabine Carboplatine

Middelen Capecitabine Carboplatine

Capecitabine/ Temozolomide

Middelen Capecitabine Temozolomide

Capecitabine/Bevacizumab

Middelen Bevacizumab Capecitabine

Capecitabine/Oxaliplatin (CapOx)

Middelen Capecitabine Oxaliplatine

CapIri

Middelen Capecitabine Irinotecan

CapIri + Bevacizumab

Middelen Bevacizumab Capecitabine Irinotecan

CapIri + Panitumumab

Middelen Capecitabine Irinotecan Panitumumab

CAPOX

Middelen Capecitabine Oxaliplatine

CAPOX + Bevacizumab

Middelen Bevacizumab Capecitabine Oxaliplatine

CAPOX/Panitumumab

CAPOX/Trastuzumab

Middelen Capecitabine Oxaliplatine Trastuzumab

Carboplatin + Gemcitabine + Nivolumab

Middelen Carboplatine Gemcitabine Nivolumab

Carboplatin + Pemetrexed + Nivolumab

Middelen Carboplatine Nivolumab Pemetrexed

Carboplatin met Radiotherapie

Middelen Carboplatine

Carboplatin-gemcitabine-pembrolizumab, neo-adjuvant

Middelen Carboplatine Gemcitabine Pembrolizumab

Carboplatin-pemetrexed-pembrolizumab, neo-adjuvant

Middelen Carboplatine Pembrolizumab Pemetrexed

Carboplatine

Middelen Carboplatine

Carboplatine/capecitabine

Middelen Capecitabine Carboplatine

Carboplatine/Etoposide

Middelen Carboplatine Etoposide

Carboplatine/Gepegyleerde liposomale doxorubicine

Middelen Carboplatine Doxorubicine (liposomaal, gepegyleerd)

Carboplatine/Vinorelbine

Middelen Carboplatine Vinorelbine

CDE

Middelen Cyclofosfamide Doxorubicine Etoposide

CEC-P

Middelen Chloorambucil Etoposide Lomustine

CEOP

Middelen Cyclofosfamide Etoposide Rituximab Vincristine

Cetuximab + Encorafenib (Braftovi®)

Middelen Cetuximab Encorafenib

CHL VPP (McElwain)

Middelen Chloorambucil Procarbazine Vinblastine

CHOEP 21

Middelen Cyclofosfamide Doxorubicine Etoposide Vincristine

CHOP 14

Middelen Cyclofosfamide Doxorubicine Vincristine

CHOP 21

Middelen Cyclofosfamide Doxorubicine Vincristine

Cisplatin + Pemetrexed+ Nivolumab

Middelen Cisplatine Nivolumab Pemetrexed

Cisplatin/Topetecan

Middelen Cisplatine Topotecan

Cisplatine

Middelen Cisplatine

Cisplatine + Gemcitabine+ Nivolumab

Middelen Cisplatine Gemcitabine Nivolumab

Cisplatine + RT

Middelen Cisplatine

Cisplatine/capecitabine+RT (chemoradiatie)

Middelen Capecitabine Cisplatine

Cisplatine/Etoposide

Middelen Cisplatine Etoposide

Cisplatine/Vinorelbine

Middelen Cisplatine Vinorelbine

Cladribine

Middelen Cladribine

CMF

Middelen Cyclofosfamide Fluorouracil (5-FU) Methotrexaat

CVP

Middelen Cyclofosfamide Vincristine

Cyclofosfamide, hoge dosis vooraf aan stamceltransplantatie

Middelen Cyclofosfamide Mercapto-ethaansulfonzuur (Mesna)

Cyclofosfamide-Bortezomb-Dexamethason (Cy-Bor-D)

Middelen Bortezomib Cyclofosfamide Dexamethason

Cytarabine it

Middelen Cytarabine

DA EPOCH R

Middelen Cyclofosfamide Doxorubicine Etoposide Rituximab Vincristine

Daratumumab injectie VRD

Middelen Bortezomib Daratumumab Dexamethason Lenalidomide

Daratumumab injectie - VTD

Middelen Bortezomib Daratumumab Dexamethason Thalidomide

Daratumumab injectie carfilzomib dexamethason

Middelen Carfilzomib Daratumumab Dexamethason

Daratumumab injectie- Bortezomib/dexamethason

Middelen Bortezomib Daratumumab Dexamethason

Daratumumab injectie- Lenalidomide/dexamethason

Middelen Daratumumab Dexamethason Lenalidomide

Daratumumab injectie- VMP (BORTEZOMIB, MELFALAN, PREDNISON)

Middelen Bortezomib Daratumumab

Daratumumab mono injectie

Middelen Daratumumab

Dasatinib

Middelen Dasatinib

dd-MVAC

Middelen Cisplatine Doxorubicine Methotrexaat Vinblastine

ddAC

Middelen Cyclofosfamide Doxorubicine

ddAC/P

Middelen Cyclofosfamide Doxorubicine Paclitaxel

ddAC/PC

Middelen Carboplatine Cyclofosfamide Doxorubicine Paclitaxel

ddAC/PPT

Middelen Cyclofosfamide Doxorubicine Paclitaxel Pertuzumab Trastuzumab

DHAC

Middelen Carboplatine Cytarabine Dexamethason

DHAP

Middelen Cisplatine Cytarabine Dexamethason

Docetaxel

Middelen Docetaxel

Docetaxel + Nintedanib

Middelen Docetaxel

Docetaxel Oxaliplatine Capecitabine in CRITICS-2

Middelen Capecitabine Docetaxel Oxaliplatine

Docetaxel/Capecitabine

Middelen Capecitabine Docetaxel

Docetaxel/Carboplatin/Trastuzumab

Middelen Carboplatine Docetaxel Trastuzumab

Docetaxel/Carboplatine

Middelen Carboplatine Docetaxel

Docetaxel/Carboplatine/Pertuzumab/Trastuzumab intraveneus

Middelen Carboplatine Dexamethason Docetaxel Pertuzumab Trastuzumab

Docetaxel/Carboplatine/Pertuzumab/Trastuzumab sc Pertuzumab/Trastuzumab

Middelen Carboplatine Docetaxel Pertuzumab Trastuzumab

Docetaxel/Cyclofosfamide

Middelen Cyclofosfamide Docetaxel

Docetaxel/Pertuzumab/Trastuzumab iv

Middelen Docetaxel Pertuzumab Trastuzumab

Docetaxel/Pertuzumab/Trastuzumab SC Pertuzumab/Trastuzumab

Middelen Docetaxel Pertuzumab Trastuzumab

Docetaxel/Prednison

Middelen Docetaxel

Docetaxel/Trastuzumab i.v.

Middelen Docetaxel Trastuzumab

Doxorubicine (sarcoom)

Middelen Doxorubicine

Doxorubicine wekelijks (low dose)

Middelen Doxorubicine

EC + Pertuzumab/Trastuzumab

Middelen Cyclofosfamide Epirubicine Pertuzumab Trastuzumab

EC + Pertuzumab/Trastuzumab sc. Pertuzumab/Trastuzumab

Middelen Cyclofosfamide Epirubicine Pertuzumab Trastuzumab

EC + Trastuzumab

Middelen Cyclofosfamide Epirubicine Trastuzumab

ECC

Middelen Capecitabine Cisplatine Epirubicine

Enzalutamide

Middelen Enzalutamide

EOX

Middelen Capecitabine Epirubicine Oxaliplatine

Eribuline

Middelen Eribuline

Erlotinib

Middelen Erlotinib

Everolimus

Middelen Everolimus

FCR (i.v.)

Middelen Cyclofosfamide Fludarabine Rituximab

FCR (oraal)

Middelen Cyclofosfamide Fludarabine Rituximab

FEC

Middelen Cyclofosfamide Epirubicine Fluorouracil (5-FU)

FEC + Docetaxel deel A

Middelen Cyclofosfamide Epirubicine Fluorouracil (5-FU)

FEC + Docetaxel deel B

Middelen Docetaxel

FLOT

Middelen Dexamethason Docetaxel Fluorouracil (5-FU) Folinezuur Oxaliplatine

FOLFIRI

Middelen Fluorouracil (5-FU) Folinezuur Irinotecan

FOLFIRI/Bevacizumab

Middelen Bevacizumab Fluorouracil (5-FU) Irinotecan

FOLFIRI/Panitumumab

Middelen Fluorouracil (5-FU) Irinotecan Panitumumab

FOLFIRINOX

Middelen Fluorouracil (5-FU) Folinezuur Irinotecan Oxaliplatine

FOLFOX 6

Middelen Fluorouracil (5-FU) Folinezuur Oxaliplatine

FOLFOX 6/panitumumab

Middelen Fluorouracil (5-FU) Folinezuur Oxaliplatine Panitumumab

FOLFOX/trastuzumab

Middelen Fluorouracil (5-FU) Folinezuur Oxaliplatine Trastuzumab

FOLFOX4

Middelen Fluorouracil (5-FU) Folinezuur Oxaliplatine

FOLFOX6 + Bevacizumab

Middelen Bevacizumab Fluorouracil (5-FU) Folinezuur Oxaliplatine

Folfoxiri/bevacizumab

Middelen Bevacizumab Fluorouracil (5-FU) Folinezuur Irinotecan Oxaliplatine

Gefitinib

Middelen Gefitinib

Gemcitabine

Middelen Gemcitabine

Gemcitabine/Capecitabine

Middelen Capecitabine Gemcitabine

Gemcitabine/Carboplatine (blaaskanker/borstkanker)

Middelen Carboplatine Gemcitabine

Gemcitabine/Carboplatine (eierstokkanker)

Middelen Carboplatine Gemcitabine

Gemcitabine/Carboplatine (longkanker)

Middelen Carboplatine Gemcitabine

Gemcitabine/Carboplatine + Carboplatine/Etoposide

Middelen Carboplatine Etoposide Gemcitabine

Gemcitabine/Carboplatine/bevacizumab

Middelen Bevacizumab Carboplatine Gemcitabine

Gemcitabine/Cisplatine (blaaskanker) Palliatief, Neo-adjuvant

Middelen Cisplatine Gemcitabine

Gemcitabine/Cisplatine (longkanker)

Middelen Cisplatine Gemcitabine

Gemcitabine/Cisplatine + PE

Middelen Cisplatine Etoposide Gemcitabine

Gemcitabine/Cisplatine poliklinisch cholangiocarcinoom

Middelen Cisplatine Gemcitabine

Gemcitabine/Nab-paclitaxel

Middelen Gemcitabine Nab-Paclitaxel (Abraxane of Pazenir)

GEMOX

Middelen Gemcitabine Oxaliplatine

GEMOX modified

Middelen Gemcitabine Oxaliplatine

Gepegyleerd liposomaal doxorubicine / Bevacizimab

Middelen Bevacizumab Doxorubicine (liposomaal, gepegyleerd)

Gepegyleerde liposomale doxorubicine

Middelen Doxorubicine (liposomaal, gepegyleerd)

HOVON 151DLBCL

Middelen Atezolizumab

HOVON 500/CLL17: Obinutuzumab + Venetoclax

Middelen Obinutuzumab Venetoclax

hydroxycarbamide

Middelen Hydroxycarbamide

Ibrutinib

Imatinib (Glivec ®)

Middelen Imatinib

Irinotecan

Middelen Irinotecan

KD (Carfilzomib dexamethason)

Middelen Dexamethason

KRD (Car len dex)

Middelen Dexamethason Lenalidomide

Lenalidomide/dexamethason

Middelen Dexamethason Lenalidomide

Lonsurf (trifluridine/tipiracilhydrochloride)

Middelen Trifluridine/tipiracil (Lonsurf)

Luspatercept

Methotrexaat bij EUG/ZOL

Middelen Methotrexaat

Methotrexaat intraveneus

Middelen Methotrexaat

Methotrexaat Post-Mola gestational trophoblastic neoplasia

Middelen Methotrexaat

methotrexaat/Cyclofosfamide

Middelen Cyclofosfamide Methotrexaat

Mitomycine/5-FU

Middelen Fluorouracil (5-FU) Mitomycine

Mitomycine/5-FU bij hoofd hals tumoren

Middelen Fluorouracil (5-FU) Mitomycine

Mitomycine/capecitabine

Middelen Capecitabine Mitomycine

Mitomycine/capecitabine/RT bij blaascarcinoom

Middelen Capecitabine Mitomycine

Mitoxantrone

Middelen Mitoxantron

Modified Folfirinox

Middelen Fluorouracil (5-FU) Irinotecan Oxaliplatine

MS: Rituximab

Middelen Rituximab

MTX it (intrathecaal)

Middelen Methotrexaat

NEO-TN ddAC

Middelen Cyclofosfamide Doxorubicine

Nilotinib

Middelen Nilotinib

Nivolumab

Middelen Nivolumab

NVALT-17: arm A (erlotinib)

Middelen Erlotinib

NVALT-17: arm B (pemetrexed/cisplatine/erlotinib)

Middelen Cisplatine Erlotinib Pemetrexed

NVALT-18: arm A (docetaxel)

Middelen Docetaxel

NVALT-18: arm B (docetaxel/erlotinib)

Middelen Docetaxel Erlotinib

obinutuzumab

Obinutuzumab Chloorambucil

Middelen Chloorambucil Obinutuzumab

Obinutuzumab Venetoclax

Middelen Obinutuzumab Venetoclax

Obinutuzumab-Bendamustine

Middelen Bendamustine Obinutuzumab

Oxaliplatin + UFT®

Middelen Folinezuur Oxaliplatine Tegafur/gimeracil/oteracil (S-1)

Oxaliplatine/Teysuno

Middelen Oxaliplatine S-1 (Teysuno)

Paclitaxel mono palliatief dag 1,8,15

Middelen Paclitaxel

Paclitaxel/Bevacizumab

Middelen Bevacizumab Paclitaxel

Paclitaxel/carbo bij triple negatief mammaca

Middelen Carboplatine Paclitaxel

Paclitaxel/Carboplatin

Middelen Carboplatine Paclitaxel

Paclitaxel/Carboplatin/Trastuzumab/Pertuzmab sc pertuzumab/Trastuzumab

Middelen Carboplatine Paclitaxel Pertuzumab/Trastuzumab (Phesgo)

Paclitaxel/Carboplatine + RT (CROSS)

Middelen Carboplatine Paclitaxel

Paclitaxel/Carboplatine + RT (T4)

Middelen Carboplatine Paclitaxel

Paclitaxel/Carboplatine 3-wkls

Middelen Carboplatine Paclitaxel

Paclitaxel/Carboplatine Maria v.d. Burg schema

Middelen Carboplatine Paclitaxel

Paclitaxel/Carboplatine wekelijks

Middelen Carboplatine Paclitaxel

Paclitaxel/Carboplatine/Bevacizumab

Middelen Bevacizumab Carboplatine Paclitaxel

Paclitaxel/Carboplatine/Bevacizumab/Atezolizumab

Middelen Atezolizumab Bevacizumab Carboplatine Paclitaxel

Paclitaxel/Carboplatine/Pembrolizumab

Middelen Carboplatine Paclitaxel Pembrolizumab

Paclitaxel/Carboplatine/Trastuzumasb i.v/Pertuzumab

Middelen Carboplatine Paclitaxel Pertuzumab Trastuzumab

Paclitaxel/Cisplatine

Middelen Cisplatine Paclitaxel

Paclitaxel/Cisplatine 3-wkls

Middelen Cisplatine Paclitaxel

Paclitaxel/Trastuzumab i.v palliatief

Middelen Paclitaxel Trastuzumab

Paclitaxel/Trastuzumab iv (neo-)Adjuvant

Middelen Paclitaxel Trastuzumab

Palbociclib

Middelen Palbociclib

Panitumumab

Middelen Panitumumab

Pazopanib

Middelen Pazopanib

PE

Middelen Cisplatine Etoposide

PECC

Middelen Chloorambucil Etoposide Lomustine

Pembrolizumab

Middelen Pembrolizumab

Pemetrexed

Middelen Pemetrexed

Pemetrexed/Carboplatine

Middelen Carboplatine Pemetrexed

Pemetrexed/Carboplatine/Pembrolizumab

Middelen Carboplatine Pembrolizumab Pemetrexed

Pemetrexed/Cisplatine

Middelen Cisplatine Pemetrexed

Pemetrexed/Cisplatine/Pembrolizumab

Middelen Cisplatine Pembrolizumab Pemetrexed

Pfizer-Bevacizumab studie

Middelen Bevacizumab Carboplatine Paclitaxel

R CEOP

Middelen Cyclofosfamide Etoposide Rituximab Vincristine

R CHOEP 21

Middelen Doxorubicine Etoposide Rituximab Vincristine

R CHOP mini

Middelen Cyclofosfamide Doxorubicine Rituximab Vincristine

R-bendamustine

Middelen Bendamustine Rituximab

R-Chloorambucil

Middelen Chloorambucil Rituximab

R-CHOP 14

Middelen Cyclofosfamide Doxorubicine Rituximab Vincristine

R-CHOP 21

Middelen Cyclofosfamide Doxorubicine Rituximab Vincristine

R-CP

Middelen Cyclofosfamide Rituximab

R-CVP

Middelen Cyclofosfamide Rituximab Vincristine

R-DC

Middelen Cyclofosfamide Dexamethason Rituximab

R-DC (cyclo i.v.)

Middelen Cyclofosfamide Dexamethason Rituximab

R-DHAC

Middelen Carboplatine Cytarabine Dexamethason Rituximab

R-DHAP

Middelen Cisplatine Cytarabine Dexamethason Rituximab

R-PECC

Middelen Chloorambucil Etoposide Lomustine Rituximab

R-VIM

Middelen Etoposide Ifosfamide Methotrexaat Rituximab

Ramucirumab/Paclitaxel

Middelen Paclitaxel Ramucirumab

REP

Rituximab (Reumatoïde Artritis)

Middelen Rituximab

Rituximab gemcitabine dexamethason cisplatina (R- GDP)

Middelen Cisplatine Dexamethason Gemcitabine Rituximab

Rituximab GemOx

Middelen Gemcitabine Oxaliplatine Rituximab

Rituximab inductiebehandeling bij ANCA geassocieerde vasculitis

Middelen Rituximab

Rituximab Lenalidomide

Middelen Lenalidomide Rituximab

Rituximab monotherapie/ inductiebehandeling (1x/week)

Middelen Rituximab

Rituximab onderhoudsbehandeling (1x/12 weken)

Middelen Rituximab

Rituximab onderhoudsbehandeling (1x/8 weken)

Middelen Rituximab

Rituximab onderhoudsbehandeling bij ANCA geassocieerde vasculitis

Middelen Rituximab

Rituximab-Venetoclax

Middelen Rituximab Venetoclax

Ruxolitinib (Jakavi ®)

Middelen Ruxolitinib

SLE: cyclofosfamide

Middelen Cyclofosfamide

Sunitinib

Middelen Sunitinib

TAD + CAD

Middelen Cyclofosfamide Dexamethason Doxorubicine Thalidomide

TAP

Middelen Cisplatine Doxorubicine Paclitaxel

TEYOX + Bevacizumab

Middelen Bevacizumab Capecitabine Oxaliplatine

Teysuno

Middelen S-1 (Teysuno)

Teysuno/Irinotecan

Middelen Irinotecan Tegafur/gimeracil/oteracil (S-1)

Topotecan (oraal)

Middelen Topotecan

Topotecan/Bevacizumab

Middelen Bevacizumab Topotecan

Trastuzumab iv /Capecitabine

Middelen Capecitabine Trastuzumab

Trastuzumab iv /Carboplatine

Middelen Carboplatine Trastuzumab

Trastuzumab iv /Docetaxel (neo)adjuvant

Middelen Docetaxel Trastuzumab

Trastuzumab iv /Docetaxel palliatief

Middelen Docetaxel Trastuzumab

Trastuzumab iv /Tegafur

Middelen Tegafur/gimeracil/oteracil (S-1) Trastuzumab

Trastuzumab iv monotherapie

Middelen Trastuzumab

Trastuzumab-Deruxtecan

Middelen Trastuzumab Deruxtecan

Trastuzumab-emtansine

Middelen Trastuzumab-Emtansine

Trastuzumab/Capecitabine/Tucatinib

Middelen Capecitabine Trastuzumab Tucatinib

Trastuzumab/Tegafur/Tucatinib

Middelen Tegafur/gimeracil/oteracil (S-1) Trastuzumab Tucatinib

Trastuzumab/Vinorelbine iv

Middelen Trastuzumab Vinorelbine

Triple B studie; CC BEV (cyclofosfamide, carboplatine en bevacizumab)

Middelen Bevacizumab Carboplatine Cyclofosfamide

TRIPLE-B studie, Arm 1a: Carboplatine/Cyclofosfamide

Middelen Carboplatine Cyclofosfamide

TRIPLE-B studie, Arm 1c: Carboplatine/Cyclofosfamide + Atezolizumab

Middelen Atezolizumab Carboplatine Cyclofosfamide

TRIPLE-B studie, Arm 2a: Paclitaxel

Middelen Paclitaxel

TRIPLE-B studie, Arm 2c: Paclitaxel + Atezolizumab

Middelen Atezolizumab Paclitaxel

VCD

Middelen Bortezomib Cyclofosfamide Dexamethason

VIM

Middelen Etoposide Ifosfamide Methotrexaat

Vinorelbine

Middelen Vinorelbine

Vinorelbine Capecitabine adjuvant

Middelen Capecitabine Vinorelbine

Vinorelbine/Capecitabine

Middelen Capecitabine Vinorelbine

VMP

Middelen Bortezomib

VMP (standaard schema)

Middelen Bortezomib

VTD

Middelen Bortezomib Dexamethason Thalidomide